These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 35871574)
1. Advances in Molecular Biological and Translational Studies in World Health Organization Grades 2 and 3 Meningiomas: A Literature Review. Okano A; Miyawaki S; Teranishi Y; Ohara K; Hongo H; Sakai Y; Ishigami D; Nakatomi H; Saito N Neurol Med Chir (Tokyo); 2022 Aug; 62(8):347-360. PubMed ID: 35871574 [TBL] [Abstract][Full Text] [Related]
2. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic. Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management. Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040 [TBL] [Abstract][Full Text] [Related]
4. Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas. Wang JZ; Patil V; Liu J; Dogan H; Tabatabai G; Yefet LS; Behling F; Hoffman E; Bunda S; Yakubov R; Kaloti R; Brandner S; Gao A; Cohen-Gadol A; Barnholtz-Sloan J; Skardelly M; Tatagiba M; Raleigh DR; Sahm F; Boutros PC; Aldape K; ; Nassiri F; Zadeh G Acta Neuropathol; 2023 Jul; 146(1):145-162. PubMed ID: 37093270 [TBL] [Abstract][Full Text] [Related]
5. Molecular landscapes of longitudinal NF2/22q and non-NF2/22q meningiomas show different life histories. Ng HK; Li KK; Chung NY; Chan JY; Poon MF; Wong QH; Kwan JS; Poon WS; Chen H; Chan DT; Shi ZF; Mao Y Brain Pathol; 2023 May; 33(3):e13120. PubMed ID: 36167400 [TBL] [Abstract][Full Text] [Related]
6. Genomic analysis of spinal meningiomas: correlation with histopathological grade. Driver J; Santagata S; Bi WL; Chi JH J Neurosurg Spine; 2023 Dec; 39(6):729-733. PubMed ID: 37728381 [TBL] [Abstract][Full Text] [Related]
7. Molecular alterations in meningioma: prognostic and therapeutic perspectives. Birzu C; Peyre M; Sahm F Curr Opin Oncol; 2020 Nov; 32(6):613-622. PubMed ID: 32890025 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index. Teranishi Y; Okano A; Miyawaki S; Ohara K; Ishigami D; Hongo H; Dofuku S; Takami H; Mitsui J; Ikemura M; Komura D; Katoh H; Ushiku T; Ishikawa S; Shin M; Nakatomi H; Saito N Acta Neuropathol Commun; 2022 May; 10(1):76. PubMed ID: 35570314 [TBL] [Abstract][Full Text] [Related]
9. [Meningiomas: new prognostic factors]. Sanz Esponera J An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599 [TBL] [Abstract][Full Text] [Related]
10. Pathological classification and molecular genetics of meningiomas. Mawrin C; Perry A J Neurooncol; 2010 Sep; 99(3):379-91. PubMed ID: 20809251 [TBL] [Abstract][Full Text] [Related]
11. DNA methylation profiling of meningiomas highlights clinically distinct molecular subgroups. Singh J; Sharma R; Shukla N; Narwal P; Katiyar A; Mahajan S; Sahu S; Garg A; Sharma MC; Suri A; Sarkar C; Suri V J Neurooncol; 2023 Jan; 161(2):339-356. PubMed ID: 36564673 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and molecular characteristics of pediatric meningiomas. Battu S; Kumar A; Pathak P; Purkait S; Dhawan L; Sharma MC; Suri A; Singh M; Sarkar C; Suri V Neuropathology; 2018 Feb; 38(1):22-33. PubMed ID: 28901666 [TBL] [Abstract][Full Text] [Related]
13. Meningiomas: Overview and New Directions in Therapy. Wang N; Osswald M Semin Neurol; 2018 Feb; 38(1):112-120. PubMed ID: 29548058 [TBL] [Abstract][Full Text] [Related]
14. [Meningioma]. Sasaki H No Shinkei Geka; 2023 Sep; 51(5):829-836. PubMed ID: 37743334 [TBL] [Abstract][Full Text] [Related]
15. Histological classification and molecular genetics of meningiomas. Riemenschneider MJ; Perry A; Reifenberger G Lancet Neurol; 2006 Dec; 5(12):1045-54. PubMed ID: 17110285 [TBL] [Abstract][Full Text] [Related]
16. Molecular pathogenesis of meningiomas. Perry A; Gutmann DH; Reifenberger G J Neurooncol; 2004 Nov; 70(2):183-202. PubMed ID: 15674477 [TBL] [Abstract][Full Text] [Related]
17. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Weber RG; Boström J; Wolter M; Baudis M; Collins VP; Reifenberger G; Lichter P Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14719-24. PubMed ID: 9405679 [TBL] [Abstract][Full Text] [Related]
18. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas. Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900 [TBL] [Abstract][Full Text] [Related]
19. Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas. Cordova C; Kurz SC Curr Oncol Rep; 2020 Jul; 22(8):84. PubMed ID: 32617743 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas. Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]